Literature DB >> 17869311

Expression of striatal adenosine and dopamine receptors in mice deficient in the p50 subunit of NF-kappaB.

Xiaobin Xie1, Krishna A Jhaveri, Ming Ding, Larry F Hughes, Linda A Toth, Vickram Ramkumar.   

Abstract

The striatal dopamine D2 receptor (D2R) and adenosine A2A receptor (A2AAR) exhibit mutually antagonistic effects through physical interactions and by differential modulation of post-receptor signaling pathways. The expression of the A2AAR and the D2R is differentially regulated by nuclear factor-kappaB (NF-kappaB). In this report, we determined the role of NF-kappaB in regulation of these receptors by comparing mice deficient in the NF-kappaB p50 subunit (p50 KO) with genetically intact B6129PF2/J (F2) mice. Quantification of adenosine receptor (AR) subtypes in mouse striatum by real time PCR, immunocytochemistry and radioligand binding assays showed more A2AAR but less A1AR in p50 KO mice as compared with F2 mice. Striata from p50 KO mice also had less D2R mRNA and [(3)H]-methylspiperone binding than did striata from F2 mice. G(alphaolf) and G(alphas) proteins, which are transducers of A2AAR signals, were also present at a higher level in striata from the p50 KO versus F2 mice. In contrast, the G(alphai1) protein, which transduces signals from the A1AR and D2R, was significantly reduced in striata from p50 KO mice. Behaviorally, p50 KO mice exhibited increased locomotor activity relative to that of F2 mice after caffeine ingestion. These data are consistent with a role for the NF-kappaB in the regulation of A1AR, A2AAR, D2R and possibly their coupling G proteins in the striatum. Dysregulation of these receptors in the striata of p50 KO mice might sensitize these animals to locomotor stimulatory action of caffeine.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17869311      PMCID: PMC2083656          DOI: 10.1016/j.lfs.2007.07.031

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  31 in total

Review 1.  Modelling of promiscuous receptor-Gi/Gs-protein coupling and effector response.

Authors:  J P Kukkonen; J Näsman; K E Akerman
Journal:  Trends Pharmacol Sci       Date:  2001-12       Impact factor: 14.819

2.  Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors.

Authors:  Joelle Hillion; Meritxell Canals; Maria Torvinen; Vicent Casado; Rizaldy Scott; Anton Terasmaa; Anita Hansson; Stanley Watson; Mark E Olah; Josefa Mallol; Enric I Canela; Michele Zoli; Luigi F Agnati; Carlos F Ibanez; Carme Lluis; Rafael Franco; Sergi Ferre; Kjell Fuxe
Journal:  J Biol Chem       Date:  2002-02-28       Impact factor: 5.157

3.  A role of p75 in NGF-mediated down-regulation of the A(2A) adenosine receptors in PC12 cells.

Authors:  Z Nie; Y Mei; R L Malek; A Marcuzzi; N H Lee; V Ramkumar
Journal:  Mol Pharmacol       Date:  1999-11       Impact factor: 4.436

4.  Nerve growth factor regulates dopamine D(2) receptor expression in prolactinoma cell lines via p75(NGFR)-mediated activation of nuclear factor-kappaB.

Authors:  Chiara Fiorentini; Nicoletta Guerra; Marco Facchetti; Alessandra Finardi; Laura Tiberio; Luisa Schiaffonati; PierFranco Spano; Cristina Missale
Journal:  Mol Endocrinol       Date:  2002-02

5.  Neuroprotective role for the p50 subunit of NF-kappaB in an experimental model of Huntington's disease.

Authors:  Z Yu; D Zhou; G Cheng; M P Mattson
Journal:  J Mol Neurosci       Date:  2000-08       Impact factor: 3.444

6.  Reduced basal and lipopolysaccharide-stimulated adenosine A1 receptor expression in the brain of nuclear factor-kappaB p50-/- mice.

Authors:  K A Jhaveri; J Reichensperger; L A Toth; Y Sekino; V Ramkumar
Journal:  Neuroscience       Date:  2007-03-09       Impact factor: 3.590

7.  Quantitative reverse transcription-polymerase chain reaction detection of cytokeratin 20 in noncolorectal lymph nodes.

Authors:  R Soong; K Beyser; O Basten; A Kalbe; J Rueschoff; K Tabiti
Journal:  Clin Cancer Res       Date:  2001-11       Impact factor: 12.531

Review 8.  The role and regulation of adenosine in the central nervous system.

Authors:  T V Dunwiddie; S A Masino
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

9.  Adenosine, prolonged wakefulness, and A1-activated NF-kappaB DNA binding in the basal forebrain of the rat.

Authors:  R Basheer; D G Rainnie; T Porkka-Heiskanen; V Ramesh; R W McCarley
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

10.  Cisplatin up-regulates the adenosine A(1) receptor in the rat kidney.

Authors:  Satyanarayan G Bhat; Snigdha Mishra; Yun Mei; Zhongzhen Nie; Craig A Whitworth; Leonard P Rybak; Vickram Ramkumar
Journal:  Eur J Pharmacol       Date:  2002-05-10       Impact factor: 4.432

View more
  4 in total

1.  Wheel running alters patterns of uncontrollable stress-induced cfos mRNA expression in rat dorsal striatum direct and indirect pathways: A possible role for plasticity in adenosine receptors.

Authors:  Peter J Clark; Parsa R Ghasem; Agnieszka Mika; Heidi E Day; Jonathan J Herrera; Benjamin N Greenwood; Monika Fleshner
Journal:  Behav Brain Res       Date:  2014-07-11       Impact factor: 3.332

2.  Adenosine receptor antagonists and behavioral activation in NF-kappaB p50 subunit knockout mice.

Authors:  Xiaobin Xie; Yashanad Mhaskar; Lydia A Arbogast; Rita A Trammell; Larry F Hughes; Linda A Toth
Journal:  Life Sci       Date:  2009-06-07       Impact factor: 5.037

3.  Nuclear Factor κB and Adenosine Receptors: Biochemical and Behavioral Profiling.

Authors:  Vickram Ramkumar; Krishna A Jhaveri; Xiaobin Xie; Sarvesh Jajoo; Linda A Toth
Journal:  Curr Neuropharmacol       Date:  2011-06       Impact factor: 7.363

Review 4.  Adenosine receptors: expression, function and regulation.

Authors:  Sandeep Sheth; Rafael Brito; Debashree Mukherjea; Leonard P Rybak; Vickram Ramkumar
Journal:  Int J Mol Sci       Date:  2014-01-28       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.